Adjuvant chemotherapy for perihilar cholangiocarcinoma: A population-based comparative cohort study

Author(s):  
Sivesh K. Kamarajah ◽  
Wasfi Al-Rawashdeh ◽  
Alessandro Parente ◽  
Phil Atherton ◽  
George I. Salti ◽  
...  
Author(s):  
Amin Andalib ◽  
Philippe Bouchard ◽  
Sebastian Demyttenaere ◽  
Lorenzo E. Ferri ◽  
Olivier Court

2019 ◽  
Vol 33 (6) ◽  
Author(s):  
Alfred Adiamah ◽  
Lu Ban ◽  
Joe West ◽  
David J Humes

SUMMARY To define the incidence of postoperative venous thromboembolism (VTE) and effects of chemotherapy in a population undergoing surgery for esophagogastric cancer. This population-based cohort study used linked primary (Clinical Practice Research Datalink) and secondary (Hospital Episode Statistics) care data from England to identify subjects undergoing esophageal or gastric cancer surgery between 1997 and 2014. Exposures included age, comorbidity, smoking, body mass index, and chemotherapy. Crude rates and adjusted hazard ratios (HRs) were calculated for rate of first postoperative VTE using Cox regression models. The cumulative incidence of VTE at 1 and 6 months was estimated accounting for the competing risk of death from any cause. Of the 2,452 patients identified, 1,012 underwent gastrectomy (41.3%) and 1,440 esophagectomy (58.7%). Risk of VTE was highest in the first month, with absolute VTE rates of 114 per 1,000 person-years (95% CI 59.32–219.10) following gastrectomy and 172.73 per 1,000 person-years (95% CI 111.44–267.74) following esophagectomy. Neoadjuvant and adjuvant chemotherapy was associated with a six-fold increased risk of VTE following gastrectomy, HR 6.19 (95% CI 2.49–15.38). Cumulative incidence estimates of VTE at 6 months following gastrectomy in patients receiving no chemotherapy was 1.90% and esophagectomy 2.21%. However, in those receiving both neoadjuvant and adjuvant chemotherapy, cumulative incidence following gastrectomy was 10.47% and esophagectomy, 3.9%. VTE rates are especially high in the first month following surgery for esophageal and gastric cancer. The cumulative incidence of VTE at 6 months is highest in patients treated with chemotherapy. In this category of patients, targeted VTE prophylaxis may prove beneficial during chemotherapy treatment.


BMC Cancer ◽  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Elinor Bexe Lindskog ◽  
Katrín Ásta Gunnarsdóttir ◽  
Kristoffer Derwinger ◽  
Yvonne Wettergren ◽  
Bengt Glimelius ◽  
...  

2020 ◽  
Vol 23 (5) ◽  
pp. 699-707
Author(s):  
Anne Bénard-Laribière ◽  
Elodie Pambrun ◽  
Anne-Laure Sutter-Dallay ◽  
Sophie Gautier ◽  
Caroline Hurault-Delarue ◽  
...  

2020 ◽  
Vol 133 (4) ◽  
pp. 1113-1119 ◽  
Author(s):  
Kristin Sjåvik ◽  
Jiri Bartek ◽  
Lisa Millgård Sagberg ◽  
Marte Lødemel Henriksen ◽  
Sasha Gulati ◽  
...  

OBJECTIVESurgery for chronic subdural hematoma (CSDH) is one of the most common neurosurgical procedures. The benefit of postoperative passive subdural drainage compared with no drains has been established, but other drainage techniques are common, and their effectiveness compared with passive subdural drains remains unknown.METHODSIn Scandinavian population-based cohorts the authors conducted a consecutive, parallel cohort study to compare different drainage techniques. The techniques used were continuous irrigation and drainage (CID cohort, n = 166), passive subdural drainage (PD cohort, n = 330), and active subgaleal drainage (AD cohort, n = 764). The primary end point was recurrence in need of reoperation within 6 months of index surgery. Secondary end points were complications, perioperative mortality, and overall survival. The analyses were based on direct regional comparison (i.e., surgical strategy).RESULTSRecurrence in need of surgery was observed in 18 patients (10.8%) in the CID cohort, in 66 patients (20.0%) in the PD cohort, and in 85 patients (11.1%) in the AD cohort (p < 0.001). Complications were more common in the CID cohort (14.5%) compared with the PD (7.3%) and AD (8.1%) cohorts (p = 0.019). Perioperative mortality rates were similar between cohorts (p = 0.621). There were some differences in baseline and treatment characteristics possibly interfering with the above-mentioned results. However, after adjusting for differences in baseline and treatment characteristics in a regression model, the drainage techniques were still significantly associated with clinical outcome (p < 0.001 for recurrence, p = 0.017 for complications).CONCLUSIONSCompared with the AD cohort, more recurrences were observed in the PD cohort and more complications in the CID cohort, also after adjustment for differences at baseline. Although the authors cannot exclude unmeasured confounding factors when comparing centers, AD appears superior to the more common PD.Clinical trial registration no.: NCT01930617 (clinicaltrials.gov)


2009 ◽  
Vol 57 (3) ◽  
pp. 403-411 ◽  
Author(s):  
Nancy N. Baxter ◽  
Sara B. Durham ◽  
Kelly-Anne Phillips ◽  
Elizabeth B. Habermann ◽  
Beth A. Virning

Sign in / Sign up

Export Citation Format

Share Document